TrialFrontiers in pharmacology2025

Bioequivalence of a single dose of two palbociclib formulations in healthy Chinese subjects under fasting conditions: a two-period crossover study with rabeprazole pre-treatment.

Wanjun Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.